Browse > Article

A Treatment of Facial Blushing with Beta Blockade and Antianxiety Drug -A report of two cases-  

Moon, Jin Cheon (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine)
Choi, Seung Ho (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine)
Yoon, Kyung Bong (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine)
Kim, Won Oak (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine)
Yoon, Duck Mi (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine)
Publication Information
The Korean Journal of Pain / v.18, no.2, 2005 , pp. 259-262 More about this Journal
Abstract
Facial blushing is a personally disabling condition, which can result in emotional disturbance and be an impediment to social life. Although numerous treatment options exist, including beta blocker, cognitive behavioral therapy and sympathetic neurolysis, no generally accepted form of treatment has been established. Herein, we report two cases of successful reduction of facial blushing following the administration of beta blocker and a minor tranquillizing antianxiety drug.
Keywords
antianxiety drug; beta blocker; facial blushing;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Drummond PD: The effect of adrenergic blockade on blushing and facial flushing. Psychophysiology 1997; 34: 163-8.
2 Fabien T, Nilsson HI. Borg K, Humble M, Pauli U: Social Phobia: the clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine, A double-blind placebocontrolled study. Acta Psychiatr Scand 1995; 92: 351-8.
3 Guttuso TJ Jr: Gabapentin's effects on the hot flashes and hypothermia. Neurology 2000; 54: 2161-3.
4 Rajesh YS, Prarap CP, Woodyer AB: Thoracoscopic sympathectomy for palmar hyperhidrosis and Raynaud's phenomenon of the upper limb and excessive facial blushing: a five year experience. Postgrad Med J 2002; 78: 682-4.
5 Neumayer CH, Bischof G, Fugger R, Imhof M, Jakesz R, Plas EG, et al: Efficacy and safety of thoracoscopic sympathicotomy for hyperhydrosis of the upper limb. Results of 734 symphathicotomies. Ann Chir Gynaecol 2001; 90: 195-9.
6 Mellander S, Andersson PO, Afzelius LE, Hellstrand P: Neural beta-adrenergic dilatation of the facial vein in man. Possible mechanism in emotional blushing. Acta Physiol Scand 1982; 114: 393-9.
7 Neumayer C, Zacher! J, Holak G, Jakesz R, Bischof G: Experience wirh limited endoscopic thoracic sympathetic block for hyperhidrosis and facial blushing. Clin Auton Res 2003; 13(Suppl 1): 152-7.
8 Yuraitis M, Jacob CI: Botulinum toxin for the treatment of facial flushing. Dermarol Surg 2004; 30: 102-4.
9 Hardman JG, Limbird LE, Gilman AG. Goodman and Gilman's the pharmacological basis of therapeutics: 10th ed. New York, The McGraw-Hill companies. 2001, pp 447-84.
10 Dratt C, Claes G, Olsson-Rex L, Dalman P, Fahlen T, Gorhberg G: Successful treatment of facial blushing by endoscopic transthoracic sympathicotomy. Bt J Derrnarol 1998; 138: 639-43.
11 Mukens S, de Jong PJ, Dobbelaar A, Bogels SM: Fear of blushing: fearful preoccupation irrespective of facial coloration. Behav Res Ther 1999; 37:1119-28.
12 Edmondson RA, Banerjee AK, Rennie JA: Endoscopic transthoracic sympathectomy in the the treatment of hyperhidrosis. Ann Surg 1992; 215: 289-93.
13 Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL: Pathophysiology and treatment of hot flashes. Mayo Clin Proc 2002; 77: 1207-18.
14 Drummond PD: A caution about surgical treatment for facial blushing. Br J Derrnarol 2000; 142: 194-5.